The DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.
Wnt signaling in cancer.
Open accessAbstract
Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology. From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biology. This article summarizes the evidence supporting a role for Wnt signaling in human cancer. This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt. I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer. Finally, some emphasis is placed on laboratory research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, APC, as a gene that upregulates WNT signaling, is negatively correlated with the frequency of T cell infiltration [196,197,198].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429 · cited 1×
“Expression of the Wnt receptor FZD7 is characteristic of these types of breast cancer (Sorlie et al. 2003).”
BackgroundWnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · cited 1×
“The impact ofb-catenin knockdown in cancers without identifiable genetic lesions in Wnt signaling could relate to the purported role of Wnt in the establishment and maintenance of so-called cancer stem cells (CSCs) (Reya and Clevers 2005; Malanchi and Huelsken 2009).”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · cited 1×
“Consequently, inhibition of target gene activation in colorectal cancer cells expressing the dominant negative TCF4 resulted in their growth arrest (Tetsu and McCormick 1999; van de Wetering et al. 2002).”
BackgroundThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169 · cited 1×
“Paradoxically, mutations in TCF4, identified through genomic sequencing efforts of colorectal cancers, appear to be inactivating by compromising its ability to repress cell growth (Sjoblom et al. 2006; Tang et al. 2008).”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“PKM2 has received considerable attention lately, although mainly because of a renewed interest in the role of metabolism and aerobic glycolysis in cancer (Christofk et al. 2008).”
BackgroundThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“Ultimately, the TCF transcription factors that associated with b-catenin completed the understanding of a basic signaling pathway that could account for the potent tumori- genic effects of Wnt (reviewed by Klaus and Birchmeier 2008).”
Backgroundvan Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543 · cited 1×
“The impact of Notch in the intestine was consistent with previous work showing that its activation or inhibition increased or decreased the population of proliferating/progenitor cells, respectively, at the expense of the differentiated population (Fre et al. 2005; van Es et al. 2005).”
ResultMorin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“Granulocyticmacrophage progenitors isolated from CML patients show attributes of excessive Wnt signaling relative to normal progenitors and the introduction of the Wnt pathway inhibitor Axin decreased their capacity for proliferation and self-renewal (Jamieson et al. 2004).”
Background
Cited by
Items 201–300 of 859
LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR‐148a‐3p/WNT1 pathway
Han, L., Yan, Y., Zhao, L., Liu, Y., Lv, X., Zhang, L., Zhao, Y., Zhao, H., He, M., & Wei, M. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15261 · Cited by 61
14‐3‐3 and β‐catenin are secreted on extracellular vesicles to activate the oncogenic Wnt pathway
Dovrat, S., Caspi, M., Zilberberg, A., Lahav‐Ariel, L., Firsow, A., Gur, H. B., & Rosin‐Arbesfeld, R. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.011 · Cited by 63
“As such,mutations orderegulated expressionof different components of theWnt pathway result in aberrant constitutive activation of the latter and may lead to the development of different diseases including cancer (Polakis, 2012) (Klaus and Birchmeier, 2008) (MacDonald et al., 2009).”
BackgroundIndole diterpene alkaloids as novel inhibitors of the Wnt/β-catenin pathway in breast cancer cells
Sallam, A. A., Ayoub, N. M., Foudah, A. I., Gissendanner, C. R., Meyer, S. A., & Sayed, K. A. E. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.09.045 · Cited by 59
The Implications of Cancer Stem Cells for Cancer Therapy
Jiang, W., Peng, J., Zhang, Y., Cho, W., & Jin, K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131216636 · Cited by 67
“regulation [101] and its dysregulation is a key factor for the initiation of various tumors [102].”
BackgroundZhang, P., Li, J., Song, Y.-Z., & Wang, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477323 · Cited by 59
RetractedHerrera-Quiterio, G. A., & Encarnación‐Guevara, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1244740 · Cited by 68
“…the development of different types of cancer such as hepatocellular carcinoma, colorectal cancer, leukemias, breast cancer and gastric cancer (94, 97 – 99 The TMEM119 gene encodes another TMEM protein in this section, also called OBIF (osteoblast induction factor) that encodes a protein that…”
BackgroundKim, T. H., Chang, J. S., Park, K., Park, J., Kim, N., Lee, J. I., & Kong, I. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171771 · Cited by 60
Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy
Lyou, Y., Habowski, A. N., Chen, G. T., & Waterman, M. L. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13963 · Cited by 58
“These advances are encouraging and suggest that the pace of drug development for Wntlinked cancers is accelerating (Kahn, 2014; Zhan et al., 2016; Nusse and Clevers, 2017).”
BackgroundMostowska, A., Pawlik, P., Sajdak, S., Markowska, J., Pawałowska, M., Lianeri, M., & Jagodziński, P. P. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0059-y · Cited by 65
“Moreover, many studies have demonstrated that the presence of mutations or polymorphisms in CTNNB1, APC, and AXIN2 can lead to aberrant activation of Wnt/b-catenin signaling at the onset of various types of malignancies, including ovarian cancer [15–31].”
BackgroundKnockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo
Dudek, H., Wong, D. H., Arvan, R., Shah, A., Wortham, K. A., Ying, B., Diwanji, R., Zhou, W. L., Holmes, B. R., Yang, H., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.233 · Cited by 57
Targeting Wnt pathway in mantle cell lymphoma-initiating cells
Mathur, R., Sehgal, L., Braun, F., Berkova, Z., Romaguera, J. E., Wang, M. L., Rodriguez, M. A., Fayad, L., Neelapu, S. S., & Samaniego, F. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0161-1 · Cited by 56
“[19–21].”
Thu, K. L., Becker‐Santos, D. D., Radulovich, N., Pikor, L. A., Lam, W. L., & Tsao, M. (2014) · Oncoscience · doi:10.18632/oncoscience.46 · Cited by 61
“This pathway plays important roles in the development of multiple organs and is aberrantly activated in several cancers, driving both cell proliferation and metastasis [57, 58].”
Renner, G., Noulet, F., Mercier, M.-C., Choulier, L., Étienne-Selloum, N., Gies, J., Lehmann, M., Lelong-Rebel, I. H., Martin, S., & Dontenwill, M. (2016) · Oncotarget · doi:10.18632/oncotarget.11552 · Cited by 61
Growth Hormone and the Epithelial-to-Mesenchymal Transition
Brittain, A. L., Basu, R., Qian, Y., & Kopchick, J. J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01000 · Cited by 60
Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes
Guimarães, P. P. G., Tan, M., Tammela, T., Wu, K., Chung, A., Oberli, M. A., Wang, K., Spektor, R., Riley, R., Viana, C. T. R., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.025 · Cited by 53
“Dysregulated activation of the Wnt signaling pathway is a key component of the proliferative potential of various cancers, and inhibition of this pathway has been shown to slow tumor growth [22].”
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
Doo, D. W., Meza‐Perez, S., Londoño, A. I., Goldsberry, W. N., Katre, A. A., Boone, J. D., Moore, D. J., Hudson, C. T., Betella, I., McCaw, T. R., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920913798 · Cited by 53
The cellular story of dishevelleds
Kafka, A., Bašić‐Kinda, S., & Pećina‐Šlaus, N. (2014) · Croatian Medical Journal · doi:10.3325/cmj.2014.55.459 · Cited by 53
Cadherin complexes recruit mRNAs and RISC to regulate epithelial cell signaling
Kourtidis, A., Necela, B. M., Lin, W., Lu, R., Feathers, R. W., Asmann, Y. W., Thompson, E. A., & Anastasiadis, P. Z. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201612125 · Cited by 56
“2 C), which are major players in epithelial cell growth (Polakis, 2012; Katsuno et al., 2013) and are intimately linked to cell adhesion (Katsuno et al.”
Pan, M., Cao, J., & Fan, Y. (2020) · Chinese Medicine · doi:10.1186/s13020-020-00338-6 · Cited by 59
The ubiquitin-like modifier FAT10 – much more than a proteasome-targeting signal
Aichem, A., & Groettrup, M. (2020) · Journal of Cell Science · doi:10.1242/jcs.246041 · Cited by 56
“…dimers with other transcription factors, phosphorylation of β-catenin, mediated by serine/threonine glycogen synthase kinase 3β (GSK3β) and by casein kinase I, leads to its ubiquitylation by the E3 ligase β-TRCP and subsequent degradation by the proteasome (Amit et al., 2002; Polakis, 2000, 2012).”
BackgroundWang, T., Liu, Z., Shi, F., & Wang, J. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2651-4 · Cited by 52
A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland
Pakula, H., Xiang, D., & Li, Z. (2017) · Cancers · doi:10.3390/cancers9020014 · Cited by 58
Mechanisms of cancer stem cell therapy
Samadani, A. A., Keymoradzdeh, A., Shams, S., Soleymanpour, A., Norollahi, S. E., Vahidi, S., Rashidy‐Pour, A., Ashraf, A., Mirzajani, E., Khanaki, K., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.08.016 · Cited by 56
Hussain, I., Eloy, J. A., Carmel, P. W., & Liu, J. K. (2013) · Journal of neurosurgery · doi:10.3171/2013.3.jns122214 · Cited by 55
Mentink, R. A., Rella, L., Radaszkiewicz, T. W., Gybeľ, T., Betist, M. C., Bryja, V., & Korswagen, H. C. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007840 · Cited by 49
CircRNA LRP6 promotes the development of osteosarcoma via negatively regulating KLF2 and APC levels.
Zheng, S., Qian, Z., Jiang, F., Ge, D., Tang, J. X., Chen, H., Jin, Y., Yao, Y., Yan, J., Zhao, L., et al. (2019) · PubMed Central · Cited by 51
Orlando, U. D., Castillo, A. F., Dattilo, M. A., Solano, A. R., Maloberti, P. M., & Podesta, E. J. (2015) · Oncotarget · doi:10.18632/oncotarget.5822 · Cited by 59
Cheng, D., Liu, J., Han, D. H., Zhang, G., Gao, W., Hsieh, M. H., Ng, N., Kasibhatla, S., Tompkins, C., Li, J., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00038 · Cited by 52
Cyclophilin A Maintains Glioma-Initiating Cell Stemness by Regulating Wnt/β-Catenin Signaling
Wang, G., Shen, J., Sun, J., Jiang, Z., Fan, J., Wang, H., Yu, S., Yu, L., Liu, Y., Bao, H., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0774 · Cited by 51
“From the early observation that overexpression of Wnt ligands leads to mammary tissue malignancy in mice, to the recent discoveries obtained from genome sequencing of tumors, deregulation of the Wnt pathway continues to evolve as a crucial mechanism in cancer biology (27).”
BackgroundGigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells
Yu, S., Wang, Z., Su, Z., Song, J., Zhou, L., Sun, Q., Liu, S., Li, S., Li, Y., Wang, M., et al. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2108-x · Cited by 52
Circulating tumor cells as “liquid biopsies” to understand cancer metastasis
Woo, D., & Yu, M. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.003 · Cited by 57
PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma
Sun, T., Co, N. N., & Wong, N. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.002 · Cited by 49
“Given that HCC is one of the most common cancer type that shows activation of Wnt pathway [19], we thus hypothesis that PFTK1 might control the Wnt signaling pathway in HCC cells via interacting with cyclin Y.”
BackgroundHseu, Y., Thiyagarajan, V., Tsou, H., Lin, K., Chen, H., Lin, C.-M., Liao, J., & Yang, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7983 · Cited by 50
“Studies suggest that involvement of the Wnt/β-catenin signaling pathway in the pathogenesis of malignant melanoma [5, 6].”
BackgroundNovakovic, B., & Saffery, R. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00285 · Cited by 49
“Many other genes are implicated in the invasive properties of EVTs, several of which are also involved in tumor progression (reviewed extensively in Soundararajan and Rao, 2004; Pollheimer and Knofler, 2005; Ferretti et al., 2007).”
BackgroundMolecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling
Pećina‐Šlaus, N., Kafka, A., & Lechpammer, M. (2016) · Cancers · doi:10.3390/cancers8070067 · Cited by 50
“Once bound to this protein complex, beta-catenin is sequentially phosphorylated on four relevant amino acids: serines 45, 37 and 33; and threonine at 41, ultimately resulting in the targeting of beta-catenin for degradation [100,101].”
BackgroundCitral induced apoptosis in MDA-MB-231 spheroid cells
Nigjeh, S. E., Yeap, S. K., Nordin, N., Kamalideghan, B., Kỳ, H., & Rosli, R. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2115-y · Cited by 51
“Axin and APC are the tumor suppressor genes that bind β-catenin and recruit CK1 to facilitate destruction of β-catenin through phosphorylation [23].”
BackgroundTherapeutics strategies against cancer stem cell in breast cancer
Ghasemi, F., Sarabi, P. Z., Athari, S. S., & Esmaeilzadeh, A. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.01.015 · Cited by 54
Dagnino, S., Bodinier, B., Guida, F., Smith-Byrne, K., Petrović, D., Whitaker, M. D., Nøst, T. H., Agnoli, C., Palli, D., Sacerdote, C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3454 · Cited by 48
“WNT/b-catenin's inappropriate activation has been linked to a wide range of cancers (39, 40).”
BackgroundHuman Papillomavirus and Cellular Pathways: Hits and Targets
Medda, A., Duca, D., & Chiocca, S. (2021) · Pathogens · doi:10.3390/pathogens10030262 · Cited by 58
Cho, S.-H., Kuo, I., Lu, P., Tzeng, H., Lai, W., Su, W., & Wang, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0915-0 · Cited by 48
Mitochondrial proteases in human diseases
Gala, M. G., & Vögtle, F. ‐. (2021) · FEBS Letters · doi:10.1002/1873-3468.14039 · Cited by 51
Developmental Pathways Hijacked by Osteosarcoma
Mortus, J., Zhang, Y., & Hughes, D. P. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_5 · Cited by 49
PKM2 promotes stemness of breast cancer cell by through Wnt/β-catenin pathway
Zhao, Z., Song, Z., Liao, Z., Liu, Z., Sun, H., Lei, B., Chen, W., & Dang, C. (2015) · Tumor Biology · doi:10.1007/s13277-015-4121-8 · Cited by 48
“survival of cancer cells [31].”
Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD
Li, A., Xu, Y., Fan, S., Meng, J., Shen, X., Xiao, Q., Li, Y., Zhang, L., Zhang, X., Wu, G., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.95874 · Cited by 48
Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance
Mehta, G., Khanna, P., & Gatza, M. L. (2019) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-019-09430-6 · Cited by 58
RNF43 truncations trap CK1 to drive niche‐independent self‐renewal in cancer
Spit, M., Fenderico, N., Jordens, I., Radaszkiewicz, T. W., Lindeboom, R. G. H., Bugter, J. M., Cristobal, A., Ootes, L., van Osch, M., Janssen, E., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103932 · Cited by 49
“Flag-Dishevelled1 DEP-C, TOPFlash, and FOPFlash luciferase reporter plasmids were described previously (Tauriello et al , 2010, 2012).”
Roarty, K. P., Pfefferle, A. D., Creighton, C. J., Perou, C. M., & Rosen, J. M. (2017) · Oncogene · doi:10.1038/onc.2017.206 · Cited by 47
“Activating mutations within the Wnt pathway are infrequent in breast cancer [19]; however, hyperactivated levels of canonical Wnt signaling exist within basal-like breast cancers [20– 22].”
β-TrCP1 Is a Vacillatory Regulator of Wnt Signaling
Long, M. J. C., Lin, H., Parvez, S., Zhao, Y., Poganik, J. R., Huang, P., & Aye, Y. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.06.009 · Cited by 49
Fasihi, A., Soltani, B. M., Atashi, A., & Nasiri, S. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26357 · Cited by 47
“Wnt signaling is a critical pathway, where its deregulation is reported in about 90% of CRC patients (Polakis 2012).”
BackgroundSignaling Pathways Induced by Leptin during Epithelial–Mesenchymal Transition in Breast Cancer
Olea‐Flores, M., Juárez-Cruz, J. C., Catalán, M. A. M., Padilla‐Benavides, T., & Navarro‐Tito, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113493 · Cited by 50
“The C-terminal domain of β-catenin may also interact with CBP–p300 and the chromatin remodeling enzyme BRG1, member of the SWI–SNF complex, allowing the transcription of c-Myc, Cyclin D1, c-Jun, fra-1 [122,127].”
Amable, G., Martínez-León, E., Picco, M. E., Siervi, N. D., Davio, C. A., Rozengurt, E., & Rey, O. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.05.004 · Cited by 48
“In most cases, the Wnt/β-catenin pathway undergoes an early deregulation that leads to the nuclear accumulation of β-catenin and the constitutive activation of its target genes (Cheah, 2009; Huels et al., 2015; Kinzler and Vogelstein, 1996; Krausova and Korinek, 2014; Polakis, 2012; Sansom et al., 2004; Walther et al.…”
BackgroundWnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion
Wang, Y., Singhal, U., Qiao, Y., Kasputis, T., Chung, J., Zhao, H., Chammaa, F., Belardo, J. A., Roth, T. M., Zhang, H., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100747 · Cited by 50
“Downstream, these interactions can lead to the release of intracellular calcium and upregulation of vimentin and snail (SNAI1), and facilitate a transition to an invasive, mesenchymal phenotype [11,23,25].”
BackgroundAilanthone: A novel potential drug for treating human cancer (Review)
Ding, H., Yu, X., Chen, H., Gao, K., Lao, X., Jia, Y., & Yan, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.11710 · Cited by 53
“Dysregulation in the Wnt/β-catenin pathway has been observed in numerous types of human cancer, such as colon cancer, melanoma, pancreas cancer and adrenocortical carcinoma (117).”
BackgroundHammerling, U., Laurila, J. B., Grafström, R., & Ilbäck, N. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.972498 · Cited by 58
“It is likewise implicated in epithelial malignancies—typified by CRC—and the associated cancer stem cells (Fearon, 2011; Polakis, 2012; White et al., 2012).”
BackgroundLee, H. C., Lim, S., & Han, J. Y. (2016) · Scientific Reports · doi:10.1038/srep34510 · Cited by 46
Structure-based prediction of Wnt binding affinities for Frizzled-type cysteine-rich domains
Agostino, M., Pohl, S., & Dharmarajan, A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.786269 · Cited by 50
“It functions to regulate body axis formation, cell fate, cell proliferation, and morphogenesis in embryonic development (2), whereas aberrant Wnt signaling is a hallmark of many cancers (3).”
BackgroundCheng, S., Qian, F., Huang, Q., Wei, L., Fu, Y.-W., & Du, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0497-x · Cited by 52
Wnt Effector TCF4 Is Dispensable for Wnt Signaling in Human Cancer Cells
Hrčkulák, D., Janečková, L., Lanikova, L., Kříž, V., Horázná, M., Babošová, O., Vojtěchová, M., Galušková, K., Šloncová, E., & Kořínek, V. (2018) · Genes · doi:10.3390/genes9090439 · Cited by 49
“Conversely, aberrant activation of the Wnt pathway increases the stem cell numbers, and initiates intestinal tumorigenesis [3,4].”
BackgroundMenbari, M., Rahimi, K., Ahmadi, A., Mohammadi‐Yeganeh, S., Elyasi, A., Darvishi, N., Hosseini, V., & Abdi, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29167 · Cited by 51
“It is a very aggressive subtype with a poor prognosis (Polakis, 2012), and it has been reported that among the TNBC cases receiving neoadjuvant chemotherapy, only 20–30% show a complete pathologic response (pCR) associated with enhanced survival (Masuda et al., 2011).”
BackgroundThe (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers
Wang, J., Nishiyama, A., Matsuyama, M., Wang, Z., & Yuan, Y. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0531-3 · Cited by 50
“indicate that the RAS [4], MAPK/ERK [5–7], V-ATPaserelated [8] and Wnt/β-catenin signaling [9] pathways contribute to cancer initiation and progression through different means.”
Chi, H.-C., Tsai, C.-Y., Wang, C.-S., Yang, H.-Y., Lo, C.-H., Wang, W.-J., Lee, K.-F., Lai, L.-Y., Hong, J.-H., Chang, Y.-F., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01390-0 · Cited by 46
Active β-catenin is regulated by the PTEN/PI3 kinase pathway: a role for protein phosphatase PP2A
Persad, A. R. L., Venkateswaran, G., Li, H., Garcia, M. E., Yoon, J., Sidhu, J., & Persad, S. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.128 · Cited by 49
“Deregulation of the Wnt signaling pathway results in increased β-catenin levels in the nucleus and consequently, the constitutive transcription of Wnt target genes [2-4].”
BackgroundInfluentialAberrant Wnt signaling: a special focus in CNS diseases
Arnés, M., & Casas‐Tintó, S. (2017) · Journal of Neurogenetics · doi:10.1080/01677063.2017.1338696 · Cited by 47
“Wnt pathway activation in cancer is caused by mutations in various signaling components including APC, b-catenin, AXIN, WTX and TCF4 (Chiurillo, 2015; Polakis, 2012), however, there are no evidences of mutations in b-catenin in GBM (Reya & Clevers, 2005).”
BackgroundRepurposing of Drugs Targeting YAP-TEAD Functions
Elisi, G. M., Santucci, M., D’Arca, D., Lauriola, A., Marverti, G., Losi, L., Scalvini, L., Bolognesi, M. L., Mor, M., & Costi, M. P. (2018) · Cancers · doi:10.3390/cancers10090329 · Cited by 51
Molecular pathways in the development of HPV-induced cervical cancer
Bonab, F. R., Baghbanzadeh, A., Ghaseminia, M., Bolandi, N., Mokhtarzadeh, A., Amini, M., Dadashzadeh, K., Hajiasgharzadeh, K., Baradaran, B., & Baghi, H. B. (2021) · EXCLI journal · doi:10.17179/excli2021-3365 · Cited by 67
Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors
Pridgeon, M. G., Grohar, P. J., Steensma, M. R., & Williams, B. O. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0377-9 · Cited by 44
Oncogenic Signaling Induced by HCV Infection
Virzì, A., Suarez, A. A. R., Baumert, T. F., & Lupberger, J. (2018) · Viruses · doi:10.3390/v10100538 · Cited by 52
“Components of the Wnt signaling are frequently mutated in liver cancer [141], which mostly result in β-catenin stabilization [142].”
BackgroundGenetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma
Fan, X., Jin, S., Li, Y., Khadaroo, P. A., Dai, Y., He, L., Zhou, D., & Lin, H. M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s225606 · Cited by 48
Chehrazi‐Raffle, A., Dorff, T. B., Pal, S. K., & Lyou, Y. (2021) · Cancers · doi:10.3390/cancers13040889 · Cited by 46
Synaptic Activity-Regulated Wnt Signaling in Synaptic Plasticity, Glial Function and Chronic Pain
Tang, S. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527312666131223114457 · Cited by 45
“Dysregulation of Wnt signaling by mutations in Wnt genes or other components of the Wnt signaling pathways is implicated in many disease conditions, especially cancers (4, 5).”
BackgroundKunttas‐Tatli, E., Roberts, D. M., & McCartney, B. M. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0885 · Cited by 49
“The exception is the sea urchin APC, which does not have an OD-1 sequence, but instead contains an N-terminal insertion of a poly-glutamine repeat.”
BackgroundWNT7A Regulation by miR-15b in Ovarian Cancer
MacLean, J. A., King, M. L., Okuda, H., & Hayashi, K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156109 · Cited by 43
“WNT signaling is well known to play an important role in cancer biology [22].”
BackgroundWnt Signaling in Chronic Rhinosinusitis with Nasal Polyps
Böscke, R., Vladar, E. K., Könnecke, M., Hüsing, B., Linke, R., Pries, R., Reiling, N., Axelrod, J. D., Nayak, J. V., & Wollenberg, B. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0024oc · Cited by 48
“Because Wnt signaling promotes proliferation in both development and disease (29, 30), we next tested for a proliferative effect of rhWNT proteins on monolayer cultures of primary HNEpCs by continuously monitoring rhWNT3Aor rhWNT4-treated cultures in an RTCA system.”
Schiefer, L., Visweswaran, M., Perumal, V., Arfuso, F., Groth, D., Newsholme, P., Warrier, S. R., & Dharmarajan, A. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2014.30 · Cited by 42
Valencia, J., Martínez, V. G., Hidalgo, L., Hernández‐López, C., Canseco, N. M., Vicente, Á., Varas, A., & Sacedón, R. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.08.015 · Cited by 42
Song, H., Zhang, Y., Liu, N., Zhao, S., Kong, Y., & Yuan, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111799 · Cited by 48
Wiese, M., Walther, N., Diederichs, C., Schill, F., Monecke, S., Salinas, G., Sturm, D., Pfister, S. M., Dressel, R., Johnsen, S. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15934 · Cited by 42
Undariopsis peterseniana Promotes Hair Growth by the Activation of Wnt/β-Catenin and ERK Pathways
Kang, J.-I., Kim, M. K., Lee, J., Jeon, Y., Hwang, E.-K., Koh, Y., Hyun, J. W., Kwon, S.-Y., Yoo, E.-S., & Kang, H. (2017) · Marine Drugs · doi:10.3390/md15050130 · Cited by 42
“The data showed that minoxidil and U. peterseniana extract increased the level of β-catenin in the nucleus through the regulation of GSK-3β [11].”
BackgroundInfluentialZhang, F., Li, Y., Xu, W., He, L., Tan, Y. L., & Xu, H. (2019) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2019.1606697 · Cited by 40
“Furthermore, β-catenin binds to the nuclear transcription factor TCF/LEF to form a transcription complex and initiate transcriptional regulation of downstream target genes, thereby exerting the cancer-promoting effect [26,27].”
BackgroundRusso, G. C., Crawford, A. J., Clark, D., Cui, J., Carney, R., Karl, M. N., Su, B., Starich, B., Lih, T. M., Kamat, P., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03007-2 · Cited by 42
“Genes encoding cell cycle related targets of E2F transcription factors.”
Tada, Y., Yamaguchi, Y., Kinjo, T., Song, X., Akagi, T., Takamura, H., Ohta, T., Yokota, T., & Koide, H. (2014) · Oncogene · doi:10.1038/onc.2013.599 · Cited by 41
Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling
Sun, X., Liu, S., Wang, D., Zhang, Y., Li, W., Guo, Y., Zhang, H., & Suo, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14834 · Cited by 44
“The canonical Wnt pathway is a central mechanism in cancer biology, either beneficial or detrimental to the prognosis of cancer patients [26].”
BackgroundNardi, I. K., Reno, T. A., Yun, X., Sztain, T., Wang, J., Dai, H., Zheng, L., Shen, B., Kim, J. H., & Raz, D. J. (2018) · International Journal of Cancer · doi:10.1002/ijc.31756 · Cited by 43
“stem cell maintenance and is also elevated in NSCLC and many other adult cancers.(11) Inhibiting Wnt signaling in both”
BackgroundLucchetta, M., da Piedade, I., Mounir, M., Vabistsevits, M., Terkelsen, T., & Papaleo, E. (2019) · BMC Cancer · doi:10.1186/s12885-019-5965-x · Cited by 44
“Frizzled-7 (FZD7) is up-regulated in LUSC, and it is a protein associated with the WNT signaling pathway [88] - a usual suspect in cancer.”
BackgroundLung, M. L., Dai, W., & Ko, J. M. Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814936-2.00002-x · Cited by 46
Liu, Z., Sneve, M., Haroldson, T. A., Smith, J. P., & Drewes, L. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.710277 · Cited by 48
Hijacking GPCRs by viral pathogens and tumor
Zhang, J., Feng, H., Xu, S., & Feng, P. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.03.021 · Cited by 44
Wagman, A. S., Boyce, R. S., Brown, S. P., Fang, E., Goff, D. A., Jansen, J. M., Le, V. P., Levine, B. H., Ng, S. C., Ni, Z., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00922 · Cited by 41
Contribution of the Wnt Pathway to Defining Biology of Glioblastoma
Tompa, M., Kálovits, F., Nagy, Á., & Kálmán, B. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8514-x · Cited by 44
Clinical Proteomics in Colorectal Cancer, a Promising Tool for Improving Personalised Medicine
Chauvin, A., & Boisvert, F. (2018) · Proteomes · doi:10.3390/proteomes6040049 · Cited by 42
“Briefly, when APC is mutated, β-catenin is not degraded, thereby leading to a constitutive activation of the Wnt/β-catenin pathway and the transcription of the genes involved in cell cycle progression, cell migration, and the inhibition of cell adhesion, ultimately promoting the development of metastases [11,12].”
BackgroundKlotho and the Treatment of Human Malignancies
Sachdeva, A., Gouge, J., Kontovounisios, C., Nikolaou, S., Ashworth, A., Lim, K. J., & Chong, I. Y.-S. (2020) · Cancers · doi:10.3390/cancers12061665 · Cited by 44
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
Vanni, I., Tanda, E. T., Dalmasso, B., Pastorino, L., Andreotti, V., Bruno, W., Boutros, A., Spagnolo, F., & Ghiorzo, P. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00172 · Cited by 47
“(Hodis et al., 2012; Polakis, 2012; Siroy et al., 2015).”
Yu, J. E., Ju, J. A., Musacchio, N., Mathias, T. J., & Vitolo, M. I. (2020) · Biomolecules · doi:10.3390/biom10121646 · Cited by 39
“The canonical Wnt/β-catenin pathway was shown to promote cancer cell proliferation, invasion, and stemness in many types of cancers including colorectal, breast, and leukemia [17].”
BackgroundZang, B., Huang, G., Wang, X., & Zheng, S.-Y. (2015) · PubMed Central · Cited by 39
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
Karim, M. E., Tha, K. K., Othman, I., Uddin, M. B., & Chowdhury, E. H. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020065 · Cited by 40
Du, Q., Zhang, X., Zhang, X., Wei, M., Xu, H., & Wang, S. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1594000 · Cited by 40
Regulation of Wnt4 in chronic obstructive pulmonary disease
Durham, A. L., McLaren, A. S., Hayes, B. P., Caramori, G., Clayton, C. L., Barnes, P. J., Chung, K. F., & Adcock, I. M. (2013) · The FASEB Journal · doi:10.1096/fj.12-217083 · Cited by 41
“birth defects and a number of cancers (14, 15).”
BackgroundAltering cancer transcriptomes using epigenomic inhibitors
Gaddis, M., Gerrard, D. L., Frietze, S. E., & Farnham, P. (2015) · Epigenetics & Chromatin · doi:10.1186/1756-8935-8-9 · Cited by 39
“Due to the hyper-activation of WNT signaling in a variety of cancer types [1,2], there has been a strong drive to develop antagonists of WNT signaling for cancer treatment.”
Distinct requirements for beta-catenin in pancreatic epithelial growth and patterning
Baumgartner, B. K., Cash, G. M., Hansen, H., Ostler, S., & Murtaugh, L. C. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.03.019 · Cited by 38
“P A A uthor M anuscript in many tissues, including mature acinar cells (Keefe et al., 2012; Polakis, 2012; Schuijers and Clevers, 2012), and decreased proliferation has been documented in β-catenin mutant pancreata, albeit at isolated time points and without reference to specific cell types…”
BackgroundLevy-Strumpf, N., & Culotti, J. G. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004381 · Cited by 39
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, P.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-03-20
- Volume
- 4
- Issue
- 5
- Pages
- a008052-a008052
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC3331705
- OpenAlex
- W2149598894
- Cited by
- 847
- References
- 94
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 41 · 2023: 36 · 2022: 56 · 2021: 85 · 2020: 76 · 2019: 77 · 2018: 76 · 2017: 95 · 2016: 89 · 2015: 64 · 2014: 54 · 2013: 51 · 2012: 13
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt signaling, cancer, epigenetic regulation, Wnt inhibitors, malignant transformation, tumor genome sequencing
- MeSH terms
- Humans, Models, Biological, Mutation, Neoplasms, Oncogene Proteins, Tumor Suppressor Proteins, Epigenesis, Genetic, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.